| Dr Robert Horace Peters, MD | |
|
190 Morgan Ave, East Haven, CT 06512-4519 | |
| (203) 469-0256 | |
| (203) 469-2458 |
| Full Name | Dr Robert Horace Peters |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 190 Morgan Ave, East Haven, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659351559 | NPI | - | NPPES |
| 001082981 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 008298 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Horace Peters, MD 190 Morgan Ave, East Haven, CT 06512-4519 Ph: (203) 469-0256 | Dr Robert Horace Peters, MD 190 Morgan Ave, East Haven, CT 06512-4519 Ph: (203) 469-0256 |
News Archive
Australia's leading health advisory body, the National Health and Medical Research Council, says there should be a five-year moratorium on any clinical research into animal-to-human whole organ transplants in Australia.
As the summer approaches do you make the most out of our time off? Do you maximise your lunch hour and time off after work? How do you revitalize yourself to make sure you feel on top of the World? Many of us forget about the small things that can instantly change the way you feel and only involve minimum impact and cost. realbuzz.com the healthy active living website suggests a few small ways to reinvigorate your regime.
In just four months since its launch, DRIVE4COPD has already encouraged more than 100,000 people to be screened to see if they may be at risk for chronic obstructive pulmonary disease. The country's newest health initiative that aims to raise awareness of COPD in the hopes that people will talk to their doctor and get diagnosed instead of suffering in silence. Currently, half of the estimated 24 million Americans who may have COPD remain undiagnosed and untreated, and most are not diagnosed until they have lost half their lung function.
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.
› Verified 7 days ago
Dr. Gordon S Weiss, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 595 Thompson Avenue, East Haven Counseling & Community Services, East Haven, CT 06512 Phone: 203-468-3297 Fax: 203-468-3334 |